Koji Sato

Career Summary, Positions, and Assignments

Apr. 1991 Joined Daiichi Pharmaceutical Company, Limited
Apr. 2019 Vice President of CMC Planning Department, Pharmaceutical Technology Unit of Daiichi Sankyo Co., Ltd.
Apr. 2021 Head of CMC Management Oncology and Head of Pharmaceutical Technology Unit of Daiichi Sankyo Inc.
Apr. 2023 Corporate officer of Daiichi Sankyo Co., Ltd.
  Director of Daiichi Sankyo Holdings and Daiichi Sankyo Inc., Head of US Corporate Division, Head of Pharmaceutical Technology Unit and Head of CMC Management Oncology of Daiichi Sankyo Inc.
Apr. 2024  Corporate Officer of Daiichi Sankyo Co., Ltd.
  Director of Daiichi Sankyo Holdings and Daiichi Sankyo Inc., Head of Project Lead and Head of Technology Unit of Daiichi Sankyo Inc.
Apr. 2025 Corporate Officer, Head of Technology Division and Head of Technology Supervisory Department of Technology Unit of Daiichi Sankyo Co., Ltd.
Apr. 2026 Senior Executive Officer, Head of Technology Unit and Head of Technology DivisionDirector of American Regent, Inc. (to present)